Mary Rusckowski Selected Research

Mary Rusckowski Research Topics

Disease

36	Neoplasms (Cancer) 09/2022 - 03/2002
7	Infections 01/2016 - 08/2003
5	Breast Neoplasms (Breast Cancer) 09/2022 - 01/2007
4	Inflammation (Inflammations) 07/2012 - 07/2004
3	Bacterial Infections (Bacterial Infection) 04/2015 - 07/2012
2	Neoplasm Metastasis (Metastasis) 12/2016 - 05/2002
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2022
1	Triple Negative Breast Neoplasms 12/2016
1	Fungal Lung Diseases 01/2013
1	Mycoses (Diseases, Fungus) 01/2013
1	Fibrosis (Cirrhosis) 02/2012
1	Colonic Neoplasms (Colon Cancer) 08/2007

Drug/Important Bio-Agent (IBA)

9	Peptides (Polypeptides)IBA 07/2012 - 05/2002
8	StreptavidinIBA 07/2012 - 03/2002
7	MorpholinosIBA 11/2013 - 03/2002
5	tumor-associated antigen 72IBA 01/2014 - 08/2007
4	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 08/2006
4	Messenger RNA (mRNA)IBA 07/2012 - 06/2009
4	Trastuzumab (Herceptin)FDA Link 07/2012 - 04/2009
4	Biotin (Vitamin H)FDA Link 07/2012 - 03/2002
3	IntegrinsIBA 09/2022 - 05/2002
3	Ribosomal RNAIBA 01/2016 - 01/2013
3	AntigensIBA 01/2014 - 05/2008
3	A-Form DNA (A-DNA)IBA 02/2011 - 03/2002
3	CY5.5 cyanine dyeIBA 07/2010 - 01/2007
2	PolymersIBA 09/2015 - 06/2004
2	bis-dipicolylamine-Zinc(II)IBA 04/2015 - 07/2012
2	Proteins (Proteins, Gene)FDA Link 02/2012 - 02/2003
2	Glycoproteins (Glycoprotein)IBA 10/2011 - 08/2007
2	AvidinIBA 12/2010 - 03/2002
2	Chelating AgentsIBA 07/2010 - 05/2008
2	OligonucleotidesIBA 06/2009 - 01/2007
2	Radioisotopes (Radionuclides)IBA 04/2009 - 12/2002
2	4-(N-maleimido)benzyltrimethylammonium (MPTA)IBA 05/2008 - 02/2008
2	Integrin beta3 (GPIIIa)IBA 02/2003 - 05/2002
1	Iohexol (Omnipaque)FDA Link 09/2022
1	Contrast MediaIBA 09/2022
1	LigandsIBA 09/2022
1	MetalsIBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2016
1	LuciferasesIBA 12/2016
1	RadiopharmaceuticalsIBA 12/2016
1	liposomal doxorubicin (Doxil)FDA Link 12/2016
1	16S Ribosomal RNAIBA 11/2013
1	LipopolysaccharidesIBA 07/2012
1	DOTA-biotin (90Y-DOTA-biotin)IBA 07/2012
1	Small Interfering RNA (siRNA)IBA 07/2012
1	InterferonsIBA 07/2012
1	Ligases (Synthetase)IBA 07/2012
1	Captopril (Capoten)FDA LinkGeneric 02/2012
1	Phosphotransferases (Kinase)IBA 02/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2012
1	Activins (Activin)IBA 02/2012
1	AminesIBA 12/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2011
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 07/2010
1	AntibodiesIBA 05/2008
1	Mepivacaine (Carbocaine)FDA LinkGeneric 05/2008
1	B72.3 antibodyIBA 05/2008
1	Technetium (Technetium 99m)IBA 05/2008
1	Complementary DNA (cDNA)IBA 11/2007
1	Antisense DNAIBA 11/2007
1	GuanineIBA 01/2007
1	Antisense OligonucleotidesIBA 01/2007
1	CytosineIBA 03/2004
1	Antimicrobial PeptidesIBA 08/2003
1	ribosomal protein S30IBA 08/2003
1	arginyl-glycyl-aspartic acidIBA 02/2003
1	tricineIBA 02/2003
1	Blood Proteins (Serum Proteins)IBA 02/2003
1	EDDA (NiEDDA)IBA 02/2003
1	Integrin alphaVbeta3IBA 05/2002
1	Cysteine (L-Cysteine)FDA Link 05/2002
1	cyclic arginine-glycine-aspartic acid peptideIBA 05/2002

Therapy/Procedure

7	Radiotherapy 01/2012 - 08/2006
5	Injections 12/2016 - 06/2004
3	Therapeutics 01/2022 - 10/2010
2	Intravenous Administration 07/2012 - 02/2011
1	Drug Therapy (Chemotherapy) 12/2016
1	Gamma Cameras (Gamma Camera) 07/2010
1	Subcutaneous Injections 07/2004